BFS
MYGN icon

Bare Financial Services’s Myriad Genetics MYGN Stock Holding History

Bare Financial Services’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05K Buy
184
+98
+114% +$445 ﹤0.01% 1359
2026
Q1 		$387 Buy
86
+31
+56% +$162 ﹤0.01% 1668
2025
Q4 		$338 Hold
55
– – ﹤0.01% 1515
2025
Q3 		$398 Sell
55
-374
-87% -$2.22K ﹤0.01% 1374
2025
Q2 		$2.28K Buy
429
+334
+352% +$1.97K ﹤0.01% 730
2025
Q1 		$843 Buy
+95
New +$1.14K ﹤0.01% 585

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bare Financial Services's MYGN Position: Q2 2026 in Review

Bare Financial Services increased its Myriad Genetics (MYGN) stake by 114% in Q2 2026, buying an estimated $445 and bringing the position to 184 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1359.

Bare Financial Services first reported a position in MYGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.28K in Q2 2025. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Bare Financial Services held 184 shares of Myriad Genetics worth $1.05K as of Q2 2026.
  • Bare Financial Services bought 98 Myriad Genetics shares in Q2 2026, an estimated $445.
  • Myriad Genetics made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #1359 holding.
  • Bare Financial Services first reported a position in Myriad Genetics in Q1 2025 and has held it in 6 quarters since.
  • Bare Financial Services's Myriad Genetics position peaked at $2.28K in Q2 2025.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.